News

Transforming Botanical Standards: A Call for Quality in Supplements

Transforming Botanical Standards: A Call for Quality in Supplements

Importance of Bioactive Standardization in Botanicals

Nootropics Depot, a leader in the supplement industry, has recently highlighted a critical issue surrounding the quality of botanical products. They urge a shift towards standardizing bioactive compounds to ensure that supplements deliver meaningful health benefits. This call follows the release of an insightful technical white paper authored by the company's President and CEO, Paul Eftang, which sheds light on the inadequacies of current quality control practices.

Challenges in Botanical Supplement Quality

Understanding the Current Landscape

Many botanical supplements fall short of delivering the intended therapeutic benefits, primarily due to a reliance on methods like DNA barcoding and macroscopic identification. Nootropics Depot emphasizes that these techniques do not adequately guarantee the presence of pharmacologically active compounds. In their examination, they utilize Tongkat Ali (Eurycoma longifolia) as a case study, revealing that numerous products either contain insufficient levels of eurycomanone or are predominantly made from spent marc—plant material left over from the extraction process. These findings raise serious concerns about the integrity of many supplements available in the market.

Identifying Subpar Extracts

Eftang's analysis particularly focuses on the extract ratios often marketed to consumers, such as 100:1 and 200:1 ratios for Tongkat Ali. The reality is stark; some of these products do not match the claimed potency according to rigorous analytical tests. When compared with native root material, they fall short, sometimes testing at or below the eurycomanone levels originally expected from the unprocessed plant.

Proposing a Hierarchy of Testing Methods

Recommendations for Enhanced Quality Assurance

To address these challenges head-on, the white paper suggests the establishment of compound-based standards, with an emphasis on utilizing High-Performance Liquid Chromatography (HPLC) or Ultra-Performance Liquid Chromatography (UPLC). These validated methods can more reliably detect adulteration. The key recommendation is the mandatory bioactive standardization for critical botanicals. For instance, specific minimum eurycomanone levels for Tongkat Ali should be established, analogous to standards for well-known compounds like ginsenosides and curcuminoids.

CEO Eftang's Vision for Product Integrity

Reflecting on the state of the industry, Paul Eftang stated, "The industry has reached a point where identity testing and inflated ratio claims are no longer acceptable proxies for quality. If products are not standardized to the compounds that actually drive their effects, consumers cannot trust what is on the label or in the bottle." This statement encapsulates Nootropics Depot's commitment to fostering trust through meaningful product standards.

Nootropics Depot's Commitment to Quality

Leading the Charge for Change

Nootropics Depot’s ongoing initiatives to enforce eurycomanone and quassinoid profiling for Tongkat Ali reflect their dedication to quality assurance. By utilizing baseline data, they can legitimately differentiate genuine extracts from those that are merely spent marc. This initiative spans across a vast catalog of over 600 products, where the aim is to standardize unique bioactives. Collaborations with industry partners are vital to Nak through its transparent approach to quality standards.

Expanding Beyond Tongkat Ali

The mission of Nootropics Depot extends well past Tongkat Ali. Their innovative bioactive standardization journey is now influencing testing methods and standards across many plants and fungi. Products range from erinacine A standardized lion's mane mycelium to ebelin lactone standardized Bacopa. This timeline illustrates a relentless pursuit of quality in the supplement industry, setting a precedent for competitors to follow.

Frequently Asked Questions

What is bioactive standardization?

Bioactive standardization refers to the process of ensuring that supplements contain specific active compounds that are known to provide health benefits, through validated testing methods.

Why is it important in supplements?

It is essential for ensuring product quality and efficacy, as consumers must be able to trust that the products they purchase contain the advertised levels of active ingredients.

How does Nootropics Depot implement these standards?

Nootropics Depot utilizes advanced testing protocols like HPLC and UPLC to quantify bioactive compounds in their products, ensuring consistency and reliability.

What are common issues in botanical supplements?

Many botanical products may not contain adequate levels of active compounds due to subpar extraction methods, reliance on identity testing, and possible misinformation on labeling.

How can consumers ensure they are getting quality supplements?

By looking for brands that prioritize bioactive standardization and provide transparency regarding their testing processes and ingredient sources.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

NextPlat Adjusts E-Commerce Goals Amid Trade Struggles

Updated Category News Views 129

Understanding NextPlat's Recent E-Commerce Adjustments NextPlat Corp (NASDAQ: NXPL), a global leader in e-commerce solutions, has announced critical changes to its operations as a response to the evolving trade landscape between the United States and China. The company anticipates that the recently imposed tariffs will significantly affect its ability to sell...

Continue Reading
Join the Exciting JiggAerobics Event for a Healthier You

Updated Category News Views 372

Join the Exciting JiggAerobics Event for a Healthier You Northeast Delta Human Services Authority (NEDHSA) is thrilled to announce its upcoming JiggAerobics event, now in its seventh installment. This lively gathering aims to promote health and fitness among people of all ages, offering a blend of fun and physical activity. Details of the Event The JiggAerobics event is...

Continue Reading
Key Insights from VanEck's Updated UK Prospectus for Investors

Updated Category News Views 172

VanEck UCITS ETFs plc: Comprehensive Prospectus Overview VanEck UCITS ETFs plc has recently issued a consolidated prospectus aimed at investors in the United Kingdom. This valuable document consolidates insights from earlier prospectus editions and offers a detailed guide into the company's shares. The consolidated prospectus serves as a transparent resource for...

Continue Reading
FirstFarms A/S Faces Challenges Amid FMD Outbreaks in Q1 Report

Updated Category News Views 148

FirstFarms A/S Reports Q1 Challenges Overview of FirstFarms' Financial Performance FirstFarms' financial results for the first quarter reveal unexpected challenges that have significantly influenced its operational landscape. The company faced notably low pig prices at the quarter's onset, accompanied by a disturbing outbreak of foot and mouth disease (FMD) affecting its...

Continue Reading
Shake Shack Reports Impressive Q4 Results Amid Expansion Plans

Updated Category News Views 236

Shake Shack's Fourth Quarter Performance Shake Shack, Inc. (NYSE: SHAK) has reported a remarkable fourth quarter, demonstrating resilience and notable growth in its financial performance. The company achieved an adjusted earnings per share of 26 cents, surpassing analysts’ expectations, which were set at 24 cents. Sales Growth and Financial Highlights During this...

Continue Reading